IP Verse

Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters

Applicant:

Opposition Date:

Dec 20, 2021

Patent Number:

Title:

Controlled Release Pharmaceutical Composition

Applicant:

Opposition Date:

Sep 29, 2021

Patent Number:

Title:

Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep Inhibitor

Applicant:

Opposition Date:

Apr 7, 2021

Patent Number:

Title:

(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof

Applicant:

Opposition Date:

Oct 15, 2019

Patent Number	Title	Applicant	Opposition Date
EP2234617	Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICA NV	Dec 20, 2021
EP2345410	Controlled Release Pharmaceutical Composition	ASTELLAS PHARMA INC.	Sep 29, 2021
EP2340828	Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep Inhibitor	NOVARTIS AG	Apr 7, 2021
EP2962690	(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof	AMGEN (EUROPE) GMBH	Oct 15, 2019

AMGEN (EUROPE) GMBH

ASTELLAS PHARMA INC.

CELGENE CORPORATION

Feel free to send us a message here and we will get back to you